Literature DB >> 33456505

Cystic fibrosis transmembrane conductance regulator in follicular fluid and cumulus cells and its relationship with age.

Yanqiu Wang1, Hui Wei1, Yazhong Ji1, Feiping Liu1, Zhijun Shen1, Xunyi Zhang1.   

Abstract

Oocyte quality deteriorates with female age and numerous indicators of oocyte quality exist. In the present study, the levels of cystic fibrosis transmembrane conductance regulator (CFTR) in the follicular fluid (FF) and cumulus cells (CCs) of infertile females in 3 different age groups were assessed to determine the relationship between CFTR and female age. The general features of the 3 groups, including age, body mass index, infertility duration, basal hormone levels and the number of retrieved oocytes were compared. The FF CFTR levels of the 3 groups were also compared and multiple age-related indicators of oocyte quality were analyzed, including the estradiol levels on the human chorionic gonadotropin injection day, the morphologically normal oocyte rate and the available or high-quality embryo rate. Immunofluorescence and PCR analyses were performed to examine CFTR expression in CCs around oocytes. The results indicated differences in general features and several indicators of oocyte quality among the 3 groups and significant differences in CFTR. The FF CFTR level was positively correlated with age, which was confirmed by immunofluorescence and PCR. Collectively, these results indicated that CFTR expression in FF and CCs may be associated with oocyte quality based on the age of individuals undergoing the assisted reproduction technique. Copyright: © Wang et al.

Entities:  

Keywords:  age; cumulus cells; cystic fibrosis transmembrane conductance regulator; follicular fluid; oocyte quality

Year:  2020        PMID: 33456505      PMCID: PMC7791913          DOI: 10.3892/etm.2020.9570

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

The developmental potential of transferred embryos is the major contributing factor to the outcomes of in vitro fertilization (IVF) cycles (1), while oocyte quality is an important factor affecting embryo quality (2). Therefore, assessing oocyte quality helps clinicians obtain the best oocytes and subsequently improve the outcomes of IVF treatment. Oocyte quality is influenced by patient-related factors, including age, body mass index (BMI) and infertility type, and external factors, such as ovarian stimulation protocols, laboratory procedures and culture conditions, although age is the most important factor (3-5). Cystic fibrosis transmembrane conductance regulator (CFTR) is a cyclic adenosine monophosphate (cAMP)-dependent chloride channel protein that is closely related to human reproductive function and participates in multiple reproductive events (6,7). CTFR is the only chloride channel in the uterus and controls secretions of the cervix and uterus to regulate a series of reproductive events such as sperm capacitation, sperm migration, oocyte fertilization and embryo implantation (8,9). When targeted to the plasma membrane, CFTR functions as a small conductance Cl- channel activated by protein kinase A-dependent phosphorylation (10). To explore novel indices for evaluating oocyte quality based on age, such as CFTR, the present study investigated the relationship between CFTR in the follicular fluid (FF) or cumulus cells (CCs) and age of the individuals.

Materials and methods

Patients

Between December 2017 and September 2018, 80 couples undergoing assisted reproductive technology (ART) treatment at Tongji Hospital of Tongji University (Shanghai, China) were recruited. Couples had male factor infertility and underwent intracytoplasmic sperm injection (ICSI) treatment were enrolled in this study. Individuals with female infertility risk factors, including fallopian tube obstruction, ovarian factor and underwent in vitro fertilization treatment were excluded from this study. The age of the females was between 25 and 42 years, their BMI ranged from 18 to 27 kg/m2 and the duration of infertility ranged from 0.6 to 10.2 years. The patients were assigned to 3 groups according to female age (group A, ≤30 years; group B, ≥31 and ≤35 years; and group C, ≥36 years) and underwent controlled ovarian stimulation with the use of a standard gonadotropin-releasing hormone agonist (GnRH-a) long protocol. GnRH-a (0.1 mg/d; Diphereline; Ipsen Pharma Biotech) was administered by intramuscular injection beginning on the 21st day of the run-in cycle for 14 days. After the menstruation and when estradiol (E2) <50 pg/ml, which indicated pituitary block, 300 IU of recombinant human follitropin (GONAL-f; Merck Serono) was administered until >2 follicles ≤18 mm in diameter were observed by vaginal ultrasound. Subsequently, human chorionic gonadotropin (HCG; LiZhu Co., Ltd.) was administered at a dose of 6,000 IU at 36 h prior to ultrasound-guided transvaginal oocyte retrieval.

Sample collection Blood serum sampling

Blood samples were obtained from all females during their menstrual cycles and on the day of HCG administration. Blood samples were kept at room temperature for 0.5 h and centrifuged at 1,000 x g for 10 min at 26˚C. Serum was isolated and stored at -80˚C.

FF collection

FF samples were collected from all females during ultrasound-guided transvaginal oocyte retrieval and FF was collected only from the first aspirated follicle with a diameter >15 mm. Oocyte retrieval needles were not flushed with any culture medium. Once the oocyte-corona-cumulus complex (OCCC) was found, the FF supernatant was preserved after centrifugation at 1,000 x g for 10 min at 26˚C and stored at -80˚C.

CC retrieval

CCs were collected from each of the 3 groups. Only the oocyte that was aspirated without flushing in the first aspiration was used to obtain cumulus cells in each patient. A petri dish containing 100 µl hyaluronidase (80 IU/ml; FUJIFILM Irvine Scientific, Inc.) in the middle and 4 20-µl droplets of gamete handling medium (G-MOPS plus; Vitrolife) around the hyaluronidase droplet was prepared. After incubation for 2 h at 37˚C in an atmosphere with 6% CO2 and 5% O2 in fertilization medium (G-IVF plus; Vitrolife), the OCCC was digested in hyaluronidase for 1 min to remove ovarian mural granulosa cells (GCs). Further mechanical denudation was performed in enzyme-free MOPS-buffered medium droplets by repeated aspiration through a Pasteur pipette with an inner diameter of 140 µm. Finally, only the CCs remaining in the MOPS-buffered medium droplets were collected for future study, while the GCs in enzyme drops were discarded. The 80 µl of MOPS-buffered medium containing the CC suspension was divided into two parts. The first 40 µl CC suspension was seeded in a cell culture dish (353001; Falcon; BD Biosciences), covered with 3 ml oil (OVOIL; FUJIFILM Irvine Scientific, Inc.) and cultured at 37˚C with 6% CO2 and 5% O2 for 24 h for subsequent immunofluorescence. The second 40-µl CC suspension was subjected to total RNA extraction for reverse transcription-quantitative (RT-q)PCR analysis.

Morphologically normal metaphase II (MII) oocyte rate calculation

After denudation, oocytes were determined to be MII oocytes when an extruded first polar body (IPB) was evident and then used for ICSI. In addition, based on the methods reported by Ubaldi and Rienzi (11), morphological assessment of the MII oocytes was performed and included the zona pellucida (ZP), perivitelline space (PVS), IPB and cytoplasm. The morphologically normal MII oocytes of the 3 groups were then calculated using the following formula: The number of morphologically normal MII oocytes/the number of total MII oocytes.

ICSI procedure and embryo culture

ICSI was performed on the heated plate (37˚C) of an inverted microscope (IX73; Olympus Corp.) with a micromanipulator system (Narishige). MII oocytes were selected for ICSI according to the method described in the Textbook of Assisted Reproductive Technologies, Third Edition (12). The injected oocytes were cultured in embryo culture medium (G-1 plus; Vitrolife) and in tissue culture dishes (cat. no. 353001; Falcon; BD Biosciences) with one oocyte per 30 µl medium.

Assessment of cleavage-stage embryos

Morphological assessment of cleavage-stage embryos was performed at 72 h after ICSI. Cleavage-stage embryo grading was based on the criteria of the Society of ART (13).

Serum hormonal measurements and FF CFTR assessment

Serum E2, LH, FSH and P levels were measured by chemiluminescence immunoassay (I2000sr; Abbott Laboratories). FF CFTR levels were determined using an ELISA kit (cat. no. CSB-EL005292HU; Cusabio Technology LLC) according to the manufacturer's protocol. The CFTR concentration was calculated according to a standard curve.

Immunofluorescence

Immunofluorescence staining was performed on the cell culture dishes containing CCs that had been retrieved from OCCC digestion 24 h earlier. CCs were fixed with 4% paraformaldehyde (Sinopharm Co., Ltd.), permeabilized with Triton X-100 (Sangon Co., Ltd.), blocked with normal goat serum (Solarbio Co., Ltd.) and then incubated with mouse anti-CFTR primary antibody (1:100 dilution; cat. no. ab2784; Abcam Co., Ltd.) at 4˚C overnight. Incubation with polyclonal goat anti-mouse immunoglobulin/FITC secondary antibody (1:50 dilution; cat. no. 33207ES60; Yeasen Co. Ltd.) was performed for 30 min at room temperature. DAPI dihydrochloride (Sangon Co., Ltd.) staining was performed to visualize nuclei. Stained samples were observed with a DM 4000 microscope (Leica Microsystems). Cell immunofluorescence images were analyzed with MATLAB R2013a (Mathworks).

RT-qPCR analysis of CFTR

CCs from each of the 3 groups were subjected to RT-qPCR to measure CFTR levels. Total RNA from CCs in 40-µl cell suspensions was extracted using RNA extraction kit (cat. no. 12183020; PureLink™ RNA Mini Kit; Invitrogen; Thermo Fisher Scientific, Inc.) and subjected to RT according to the protocol provided by the manufacturer of the BeScript One Step RT-PCR Kit (cat. no. CV003; Shanghai Colegen biological technology Co., Ltd.; http://www.colegen.com/products_16/28.html). RT-qPCR for CFTR was performed with Perfect SYBR Green Master Mix (cat. no. V001; Shanghai Colegen Biological Technology Co., Ltd.; http://www.colegen.com/products_16/31.html) and CFTR levels were normalized to the β-actin endogenous control gene. A 7500 Sequence Detection System (SDS; Applied Biosystems; Thermo Fisher Scientific, Inc.) was used to monitor the reaction procedure. The primers were as follows: CFTR sense, 5'-TGTAAATGGAGGAGGAAATG-3' and antisense, 5'-GAGAAGATGATAAGTGGGAAA-3'; and β-actin sense, 5'-CTGGGACGACATGGAGAAAA-3' and antisense, 5'-AAGGAAGGCTGGAAGAGTGC-3'. The PCR conditions were as follows: 5 min at 95˚C, then 35 cycles of 15 sec at 95˚C and 15 sec at 60˚C, followed by 10 min at 72˚C. Raw data were analyzed by ABI Prism 7500 SDS Software (Applied Biosystems; Thermo Fisher Scientific, Inc.) The RT-qPCR results were quantified using the 2-ΔΔCq method (14).

Statistical analysis

SPSS 20.0 statistical software (IBM Corp.) was used for data analysis. The measurement data are expressed as the mean ± standard error of the mean. Statistical analysis for each variable was performed using one-way ANOVA followed by Duncan's post-hoc test. The multiple imputation method was used to manage inconsistent numbers of cases between groups (15). The correlation between CFTR level in FF and E2 on HCG injection day was analyzed by Pearson's linear correlation analysis. P<0.05 was considered to indicate statistical significance.

Results

Comparison of the general conditions of the patients

Basal hormone levels during the menstrual cycles of the 80 female patients in the 3 groups were measured and data on the numbers of OCCCs retrieved were also recorded. No significant differences in BMI and LH were observed among the three groups (P>0.05). Significant differences in infertility duration, E2, FSH, P and OCCC number were identified among the groups (P<0.05; Table I).
Table I

Basic demographic and laboratory data of the patients.

ParameterGroup A (n=32)Group B (n=29)Group C (n=19)P-value
Age (years)25.88±2.0132.25±1.1937.62±1.47<0.001
BMI (kg/m2)20.9±2.121.7±2.223.0±4.80.468
Duration of infertility (years)3.6±1.92.8±1.97.1±4.40.002
E2 (pmol/l)279.58±71.02214±121.21195.08±57.260.009
LH (IU/l)5.39±3.193.95±1.585.13±3.270.400
FSH (IU/l)4.19±1.45.81±1.596.73±1.60.004
P (nmol/l)1.76±0.491.79±0.641.35±0.410.042
OCCC number10.8±7.28.1±5.04.2±4.50.001

Values are presented as the mean ± standard error of the mean. Groups: A, ≤30 years; B, ≥31 and ≤35 years; and C, ≥36 years. BMI, body mass index; E2, estradiol; LH, luteinizing hormone; FSH, follicle-stimulating hormone; P, progesterone; OCCC, oocyte-corona-cumulus complex.

Association of FF CFTR levels with indicators of oocyte quality

The level of FF CFTR on the day of oocyte retrieval in group C was significantly higher than that in group A or group B and it was higher in group B than that in group A (P<0.001; Table II). The level of E2 on HCG injection day decreased with increasing age, where the difference of E2 among the three groups was statistically significant with that in group C the lowest (P<0.05; Table II). A significant but weak negative correlation was identified among the three groups of FF CFTR levels and E2 levels on the HCG injection day (r=-0.131; P=0.021; Fig. 1). There were no statistical differences in the morphologically normal MII oocyte rate and available embryo rate among the three groups, but the rate of high-quality embryos declined with age, with that in group C the lowest (P<0.05; Table II).
Table II

Indicators of oocyte quality.

ParameterGroup A (n=32)Group B (n=29)Group C (n=19)P-value
CFTR in FF (ng/ml)52.94±25.5175.29±29.2992.68±29.94<0.001
E2 on HCG injection day (nmol/l)10.70±6.8410.65±8.075.81±5.180.021
Morphologically normal MII oocyte rate (%)80.3478.9173.560.066
Available embryo rate (%)63.6980.4360.610.089
High-quality embryo rate (%)58.3340.5833.330.019

Values are presented as the mean ± standard error of the mean or percentage. Groups: A, ≤30 years; B, ≥31 and ≤35 years; and C, ≥36 years. E2, estradiol; CFTR, cystic fibrosis transmembrane conductance regulator; FF, follicular fluid; MII, metaphase II; HCG, human chorionic gonadotropin.

Figure 1

Dot plot of the correlation between CFTR and estradiol levels among the three groups. CFTR, cystic fibrosis transmembrane conductance regulator; E2, estradiol.

Localization and expression of CFTR in cumulus GCs

CFTR expression in CCs (red expression) was detected by immunofluorescence staining and was consistent with that denoted in Gene Cards®. The fluorescence intensity of CFTR in group C was higher than that in group B, while group A had the lowest intensity (Fig. 2).
Figure 2

Immunofluorescence staining of CCs for CFTR in (A) group A, (B) group B and (C) group C. On the cell culture dish with CCs, CFTR (red) was readily detected in the cytoplasm. The nuclei were stained with DAPI (blue) (magnification, x400; scale bar, 50 µm). (D) Fluorescence intensity histogram for the 3 groups. Groups: A, ≤30 years; B, ≥31 and ≤35 years; and C, ≥36 years. CCs, cumulus cells; CFTR, cystic fibrosis transmembrane conductance regulator.

There are ~500 CCs around each oocyte and half of the total CCs in each group were used for RT-qPCR. Due to the limitation of sample size analysis in each group was performed twice. The RT-qPCR results were analyzed using the 2-ΔΔCq method. Analysis of the three groups suggested that the mean 2-ΔΔCq value of two experimental replicates increased with age and there were significant differences between groups A and C, and between groups B and C (P<0.01), where group C had the highest value of 2-ΔΔCq (Fig. 3).
Figure 3

Reverse transcription-quantitative PCR analysis of CFTR and β-actin expression. *P<0.01. Groups: A, ≤30 years; B, ≥31 and ≤35 years; and C, ≥36 years. CFTR, cystic fibrosis transmembrane conductance regulator.

Discussion

Among the patient groups of the present study, differences in proven age-associated indicators were identified, suggesting that the selected patients were representative of the general population (16). Numerous indicators of oocyte quality exist, but each method has its own shortcomings (17). Oocyte morphological assessment is the most widely used method in clinical practice; a normal human MII oocyte should have a round and clear ZP, a small PVS containing a single IPB without fragmentation and pale, moderately granular cytoplasm with no inclusions (18). However, oocyte morphological assessment may be performed only after oocyte denudation in ICSI cases and potential mechanisms that change the appearance of the oocyte are multifactorial (19). Age and the E2 level on the HCG day are indirect indicators (20). Embryo quality reflects oocyte quality only retrospectively and neglects sperm-related factors (21). Therefore, an index that is able to evaluate oocyte quality prior to IVF is still required. The present results indicated that with increasing age, no significant changes in certain commonly used indicators of oocyte quality occurred, although CFTR was more positively correlated with age than these indicators. The CFTR is an anion channel regulated by cAMP-dependent phosphorylation and is expressed in epithelial cells of a wide variety of tissue types, including the reproductive tracts (22). CFTR affects factors including sperm transport, blastocyst implantation, sperm capacitation and function by regulating fluid volume and bicarbonate secretion in the reproductive tract (23). The cumulus GC layer regulates oocyte maturation and development through complex mechanisms such as gap junctions (23). Detecting gene expression in GCs may reflect changes in the follicular microenvironment and further provide relevant information on oocyte development (24). Evaluating egg quality and embryonic development potential indirectly is helpful. In the present study, CFTR expression in CCs was detected by indirect immunofluorescence and the results suggested that CFTR was mainly localized to the cumulus GC cytoplasm and membrane. The RT-qPCR results also further demonstrated that CFTR gene expression in cumulus GCs may have a positive correlation with age and may affect the outcome of embryo development. In order to clarify the relationship between the mature oocytes and the patient's age, only the FF and CCs around mature oocytes obtained by the first aspiration without rinsing were collected. FF or CCs were excluded if there was no OCCC found or the oocytes were immature. Therefore, the number of cases enrolled is limited, particularly in group C. To verify this result, it is required to increase the sample sizes of the different age groups. In assisted reproductive technology, FF metabonomics may be combined with other clinical factors such as age to predict the quality of oocytes and other important information (25). Multiple studies have examined correlations between lipid metabolism, amino acid metabolism or glucose metabolism in FF and oocyte quality (26). Certain studies have indicated that the levels of fatty acids in FF are related to oocyte maturity and that certain changes in fatty acids may improve oocyte quality (27). Regarding amino acid metabolism, amino acids in FF have an important role in oocyte maturation and fertilization and evaluating oocyte quality according to amino acid levels in FF is a current research hotspot (28). Regarding glycometabolism, Robker et al (29) observed that glucose levels in the FF of fertilized eggs with failed cleavage are significantly higher compared with those in the FF of fertilized eggs with normal cleavage, indicating that low oocyte quality is related to high glucose levels in FF. In the present study, CFTR levels were compared with several classical indexes used to evaluate oocyte quality to identify novel correlations and the correlation between age and the CFTR level in FF was confirmed for the first time, to the best of our knowledge, i.e. that the CFTR level in FF is positively correlated with age. Due to the limited cases enrolled in this study, further research is needed. Although the identification of specific predictive biochemical markers is not yet possible, this method has potential application value. FF metabonomics analysis is expected to open a new chapter in the screening of high-quality oocytes and embryos.
  28 in total

1.  Standardization of grading embryo morphology.

Authors:  Catherine Racowsky; Michael Vernon; Jacob Mayer; G David Ball; Barry Behr; Kimball O Pomeroy; David Wininger; William Gibbons; Joseph Conaghan; Judy E Stern
Journal:  Fertil Steril       Date:  2010-07-02       Impact factor: 7.329

2.  Dithiothreitol prevents age-associated decrease in oocyte/conceptus viability in vitro.

Authors:  J J Tarín; J Ten; F J Vendrell; A Cano
Journal:  Hum Reprod       Date:  1998-02       Impact factor: 6.918

Review 3.  Paternal factors contributing to embryo quality.

Authors:  Stacy Colaco; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2018-09-11       Impact factor: 3.412

4.  Oocyte retrieval and quality evaluation.

Authors:  Lucinda Veeck Gosden
Journal:  Methods Mol Biol       Date:  2014

Review 5.  Retrospective assessment of an assisted reproductive technology method.

Authors:  Siham Aboulmakarim; Amal Benbella; Houyam Hardizi; Rachid Bezad
Journal:  Ann Biol Clin (Paris)       Date:  2018-01-01       Impact factor: 0.459

6.  Selection of good embryos for transfer depends on embryo cohort size: implications for the 'mild ovarian stimulation' debate.

Authors:  F Devreker; E Pogonici; V De Maertelaer; P Revelard; M Van den Bergh; Y Englert
Journal:  Hum Reprod       Date:  1999-12       Impact factor: 6.918

7.  Expression of cystic fibrosis transmembrane conductance regulator in human endometrium.

Authors:  Xiao-Ying Zheng; Gui-An Chen; Hai-Yan Wang
Journal:  Hum Reprod       Date:  2004-10-07       Impact factor: 6.918

Review 8.  Structure and function of the CFTR chloride channel.

Authors:  D N Sheppard; M J Welsh
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

Review 9.  Oleic acid in the modulation of oocyte and preimplantation embryo development.

Authors:  Shabnam Fayezi; Jo L M R Leroy; Marefat Ghaffari Novin; Masoud Darabi
Journal:  Zygote       Date:  2017-12-15       Impact factor: 1.442

10.  An overview of gene expression dynamics during early ovarian folliculogenesis: specificity of follicular compartments and bi-directional dialog.

Authors:  Agnes Bonnet; Cedric Cabau; Olivier Bouchez; Julien Sarry; Nathalie Marsaud; Sylvain Foissac; Florent Woloszyn; Philippe Mulsant; Beatrice Mandon-Pepin
Journal:  BMC Genomics       Date:  2013-12-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.